Immix Biopharma Inc (IMMX) — Financial Flexibility Index
Immix Biopharma Inc (IMMX) has a Financial Flexibility Index of -0.86x as of March 2026. Free cash flow of $-9.79 Million (operating CF $-9.83 Million minus capex $32.49K) represents -1% of total liabilities ($11.45 Million). Also explore Immix Biopharma Inc (IMMX) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immix Biopharma Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Immix Biopharma Inc across 7 annual periods. Check Immix Biopharma Inc (IMMX) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Immix Biopharma Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Immix Biopharma Inc. For the full company profile including market capitalisation, see Immix Biopharma Inc (IMMX) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.10x | $-23.20 Million | $-23.93 Million | $11.04 Million | ▼ -51.8% |
| 2024 | -1.38x | $-13.42 Million | $-14.60 Million | $9.70 Million | ▲ +54.5% |
| 2023 | -3.04x | $-11.32 Million | $-11.37 Million | $3.72 Million | ▲ +28.2% |
| 2022 | -4.24x | $-7.41 Million | $-7.41 Million | $1.75 Million | ▲ +46.1% |
| 2021 | -7.86x | $-1.59 Million | $-1.59 Million | $202.04K | ▼ -10139.0% |
| 2020 | -0.08x | $-404.69K | $-404.69K | $5.27 Million | ▲ +55.0% |
| 2019 | -0.17x | $-782.72K | $-790.03K | $4.59 Million | — |